A. Szczepańska-Szerej

发表

Clinical and biochemical predictors of late-outcome in patients after ischemic stroke.

K. Rejdak, Beata Daniluk, P. Kamieniak, 2020, Annals of agricultural and environmental medicine : AAEM.

The effectiveness of patent foramen ovale closure and antiplatelet or anticoagulant therapies for cryptogenic ischemic stroke

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2018 .

The international normalized ratio (INR) as seen in a population of patients with atrial fibrillation and cerebral infarction undergoing long-term treatment with vitamin K antagonists

Beata Szajnoga, A. Szczepańska-Szerej, Magdalena Wojtan, 2015 .

Pain in cervical dystonia and the antinociceptive effects of botulinum toxin: what is currently known?

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2019, Reviews in the neurosciences.

Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2020, Neurological research.

Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A

K. Rejdak, E. Papuć, A. Szczepańska-Szerej, 2020, The International journal of neuroscience.

Pain incidence in cervical dystonia is determined by the disease phenotype

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2020, Journal of Clinical Neuroscience.

Cervical dystonia: pain relieving effects of botulinum toxin treatment. Journal of Education, and Cervical dystonia: pain relieving effects of botulinum toxin treatment

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2018 .

Non-traumatic cervical artery dissection and ischemic stroke: A narrative review of recent research

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2019, Clinical Neurology and Neurosurgery.

Simvastatin-induced prevention of the increase in TNF-alpha level in the acute phase of ischemic stroke.

Z. Stelmasiak, J. Wojczal, J. Kurzepa, 2007, Pharmacological reports : PR.

Simvastatin could prevent increase of the serum MMP-9/TIMP-1 ratio in acute ischaemic stroke.

Z. Stelmasiak, T. Małecka-Massalska, J. Kurzepa, 2006, Folia biologica.

PO13-TU-14 Simvastatin presents an anti-oxidative effect in patients with acute ischemic stroke resulted in protection of the serum 8-isoprostane increase

Z. Stelmasiak, J. Wojczal, J. Kurzepa, 2009, Journal of the Neurological Sciences.

Simvastatin inhibits the increase in serum tau protein levels in the acute phase of ischemic stroke.

Z. Stelmasiak, H. Bartosik-Psujek, J. Bielewicz, 2008, Pharmacological reports : PR.

The influence of hydrophilic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (pravastatin) on gelatinase activity in vitro

J. Kurzepa, A. Szczepańska-Szerej, J. Kurzepa, 2009 .

Simvastatin Displays an Antioxidative Effect by Inhibiting an Increase in the Serum 8-Isoprostane Level in Patients With Acute Ischemic Stroke: Brief Report

Z. Stelmasiak, J. Wojczal, J. Kurzepa, 2011, Clinical neuropharmacology.

Optimization of pain management in cervical dystonia

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2018 .

Oligoclonal bands as predictors of multiple sclerosis inclinically isolated syndrome

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2018 .

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

R. Sabatowski, R. Baron, H. Kress, 2012, Current medical research and opinion.

New Highlights in the Treatment of Progressive Multiple Sclerosis

K. Rejdak, A. Jamroz-Wiśniewska, A. Szczepańska-Szerej, 2018 .

Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.

K. Rejdak, A. Jamroz-Wiśniewska, A. Szczepańska-Szerej, 2020, Neurologia i neurochirurgia polska.

Wernicke-Korsakoff syndrome as a rare phenotype of sporadic Creutzfeldt-Jakob disease

K. Rejdak, K. Wojtal, J. Bielewicz, 2018, Prion.

Progressive forms of multiple sclerosis: disease-modifying therapy review

K. Rejdak, A. Jamroz-Wiśniewska, A. Szczepańska-Szerej, 2018 .

[Detection of cerebral microemboli by transcranial doppler. Technical aspects].

Z. Stelmasiak, J. Wojczal, A. Szczepańska-Szerej, 2002, Neurologia i neurochirurgia polska.

Prevention of seizures after ischemic stroke : association between statin use and the risk of seizures

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2018 .

Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome

K. Rejdak, A. Grabarska, J. Bielewicz, 2017, International journal of endocrinology.

Mechanical thrombectomy in acute stroke - Five years of experience in Poland.

S. Ochudło, D. Ryglewicz, J. Jaworski, 2017, Neurologia i neurochirurgia polska.

A rare neurological manifestation of a malnourished alcohol-dependent acute pancreatitis patient with Marchiafava–Bignami disease

K. Rejdak, K. Pyra, Maciej Szmygin, 2020, Gastroenterology report.

Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study.

S. Ochudło, P. Sobolewski, J. Maciejewska, 2020, Neurologia i neurochirurgia polska.

Simvastatin inhibits the increase in serum tau protein levels in the acute phase of ischemic stroke.

Z. Stelmasiak, H. Bartosik-Psujek, J. Bielewicz, 2008, Pharmacological reports : PR.

A comment on the paper 'Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors' by Sapko et al.

K. Rejdak, A. Szczepańska-Szerej, M. Marciniec, 2020, Neurologia i neurochirurgia polska.